Finance / United States
If you would like to subscribe to Corporate Financing Week and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Corporate Financing Week please click on the trial link below.
CVS' US$2.9bn Bid For Longs
August 2008 | M&A News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Corporate Financing Week and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Corporate Financing Week please click on the trial link below.
Yet more activity in the pharmaceutical industry, as US giant CVS Caremark agrees to pay US$2.9bn for Longs Drug Stores, in a bid to penetrate the lucrative West coast market. The US$71.50 per share cash offer represents a 32% premium over Longs' closing price on August 11 2008. CVS plans to finance the acquisition, which includes up to US$360mn in debt, with a US$1.5bn bridge loan, together with existing cash and liquidity. Subject to review under the Hart-Scott-Rodino Act, the deal is expected to be completed by the end of 2008. CVS expects to achieve significant cost synergies of US$100mn in 2009 and US$140-150mn in 2010, resulting from purchasing efficiencies and a reduction in SG&A expense.